Understanding immune reaction to the hepatitis B virus

November 28, 2016, Kumamoto University
(A) Infection and tissue sampling timeline. (B & C) Heatmaps of all genes expressed in the liver after HBV infection as assessed by a next-generation sequencer. Upregulated genes are shown in C-left, downregulated genes in C-center, and unchanged genes are shown in C-right.Image adapted from Kouwaki et al. (DOI: 10.3389/fimmu.2016.00335). Credit: Professor Hiroyuki Oshiumi

A collaboration of researchers from Japan and Malaysia has further clarified the immune response to hepatitis B virus through in vivo experimentation.

The system in mammals defends against infection from viruses and other microbial infections. Unfortunately, the human to the hepatitis B (HBV) is not yet fully understood. Without vaccination, hepatitis B causes both acute and chronic infections of the liver, and can lead to the development of cirrhosis and liver cancer. To gain a deeper understanding of how the reacts to HBV, researchers from several institutions in Japan and Malaysia led by Professor Hiroyuki Oshiumi of Kumamoto University performed in vivo experiments on the tree shrew, a small mammal that is also prone to HBV infection.

Infection was successful in just over half (55%) of the animals injected with the virus suggesting that a large portion of tree shrews have a natural immunity to HBV. The cytokine interferon-gamma (IFN-gamma), which plays an important role in the activation and modulation of the immune system and in impeding the ability of a virus to replicate, was found early (1 day after infection) in the infected population. This is thought to be caused by the activation of hepatic natural killer (NK) cells in reaction to HBV infection. Further analysis added to the growing body of evidence supporting claims of antiviral actions of IFN-gamma on HBV by confirming that IFN-gamma prompts hepatocyte expression of the DDX60 gene. Expression of this gene causes the degeneration of HBV RNA.

Importantly, the researchers also found that extracellular vesicles (EV) are integral to the innate immune response to HBV . "We showed that EVs coming from HBV-infected hepatocytes carry viral nucleic acids which, in turn, stimulates the innate immune response against HBV," said Professor Oshiumi. "However, we also found that HBV can escape the immune response by increasing the immunosuppressive microRNA levels in exosomes. The increase of these microRNAs eventually results in a reduction of NK cell activation which allows HBV to easily proliferate."

The results of this research opens a new window into the to the hepatitis B virus and provides further insight into the molecular mechanisms involved. The full article can be found online in the open-access journal Frontiers in Immunology.

Explore further: Inflammation triggers unsustainable immune response to chronic viral infection

More information: Takahisa Kouwaki et al, Extracellular Vesicles Including Exosomes Regulate Innate Immune Responses to Hepatitis B Virus Infection, Frontiers in Immunology (2016). DOI: 10.3389/fimmu.2016.00335

Related Stories

Inflammation triggers unsustainable immune response to chronic viral infection

October 21, 2016
Scientists at the University of Basel discovered a fundamental new mechanism explaining the inadequate immune defense against chronic viral infection. These results may open up new avenues for vaccine development. They have ...

Team identifies how hepatitis A virus causes liver injury

September 15, 2016
Hepatitis researchers have long thought that immune cells sent by the body to attack virus-infected cells in the liver cause the acute liver injury associated with hepatitis A virus (HAV) and other hepatitis viruses. Yet, ...

When suppressing immunity is a good thing

June 21, 2016
A receptor, first known for its role in mediating the harmful effects of the environmental pollutant dioxin in our body, is now understood to play other important roles in modulating the innate immune response.

High viral load in HIV-infected individuals underlies innate immune cell dysfunction

March 17, 2016
Individuals infected with HIV exhibit both severe immune deficiency and aberrant inflammation, resulting in susceptibility to secondary infection as the disease progresses. HIV-associated deficiencies in adaptive immune responses ...

Study finds how the immune system responds to hepatitis A virus

June 20, 2011
A surprising finding in a study comparing hepatitis C virus (HCV) with hepatitis A virus (HAV) infections in chimpanzees by a team that includes scientists from the Texas Biomedical Research Institute sheds new light on the ...

Compound found to trigger innate immunity against viruses

December 17, 2015
Research from UW Medicine and collaborators indicates that a drug-like molecule can activate innate immunity and induce genes to control infection in a range of RNA viruses, including West Nile, dengue, hepatitis C, influenza ...

Recommended for you

Novel genomic tools provide new insight into human immune system

January 19, 2018
When the body is under attack from pathogens, the immune system marshals a diverse collection of immune cells to work together in a tightly orchestrated process and defend the host against the intruders. For many decades, ...

Genomics reveals key macrophages' involvement in systemic sclerosis

January 18, 2018
A new international study has made an important discovery about the key role of macrophages, a type of immune cell, in systemic sclerosis (SSc), a chronic autoimmune disease which currently has no cure.

First vaccine developed against grass pollen allergy

January 18, 2018
Around 400 million people worldwide suffer in some form or other from a grass pollen allergy (rhinitis), with the usual symptoms of runny nose, cough and severe breathing problems. In collaboration with the Viennese firm ...

Researchers discover key driver of atopic dermatitis

January 17, 2018
Severe eczema, also known as atopic dermatitis, is a chronic inflammatory skin condition that is driven by an allergic reaction. In their latest study, researchers at La Jolla Institute reveal an important player that promotes ...

Who might benefit from immunotherapy? New study suggests possible marker

January 16, 2018
While immunotherapy has made a big impact on cancer treatment, the fact remains that only about a quarter of patients respond to these treatments.

Researchers identify new way to unmask melanoma cells to the immune system

January 16, 2018
system, which enables these deadly skin cancers to grow and spread.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.